Replies to post #321600 on Avid Bioservices Inc (CDMO)

[biopharm]

Dr Jedd Wolchok working with PS Targeting and was scheduled this month:

Keystone Symposia Jan 16-20 2018

Before:

T Cell Dysfunction, Cancer and Infection (A3)

Scientific Organizers: Daniel C. Douek, W. Nicholas Haining and Jedd D. Wolchok

January 16—20, 2018
Beaver Run Resort, Breckenridge, Colorado, USA

Sponsored by Incyte Corporation, Juno Therapeutics and TESARO, Inc.


....and on Thursday Jan 18th 5pm-7pm timeslots Dr Jedd Wolchok was publicly listed in this section and Dr Wolchok scheduled to speak about results of combined checkpoint blockades as seen below


"Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, USA
Clinical Results of Combined Checkpoint Blockades "

_______________________________

After:

(Now it is missing...) although Dr Wolchok still listed as scientific organizer as he was from before though new sponsors popped up Amgen, Merck, Regeneron and Surface Oncology as seen below:

"T Cell Dysfunction, Cancer and Infection (A3)
Scientific Organizers: Daniel C. Douek, W. Nicholas Haining and Jedd D. Wolchok

January 16—20, 2018
Beaver Run Resort, Breckenridge, Colorado, USA

Sponsored by Amgen Inc., Incyte Corporation, Juno Therapeutics, Merck & Co., Inc., Regeneron Pharmaceuticals, Inc., Surface Oncology and TESARO, Inc."